Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio,
deputy editor of The Lancet Respiratory Medicine, to discuss the
ENDTB-Q trial to evaluate the efficacy and safety of a drug
regiment to treat TB in individuals with pre-extensively
drug-resistant tuberculosis.


Read the full article:


https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv